Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Kura Oncology (KURA) over the last 5 years, with Dec 2024 value amounting to -$2.02.

  • Kura Oncology's EPS (Weighted Average and Diluted) fell 34.92% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.48, marking a year-over-year change of. This contributed to the annual value of -$2.02 for FY2024, which is 2.88% up from last year.
  • According to the latest figures from FY2024, Kura Oncology's EPS (Weighted Average and Diluted) is -$2.02, which was up 2.88% from -$2.08 recorded in FY2023.
  • In the past 5 years, Kura Oncology's EPS (Weighted Average and Diluted) ranged from a high of -$1.69 in FY2020 and a low of -$2.08 during FY2023.
  • In the last 3 years, Kura Oncology's EPS (Weighted Average and Diluted) had a median value of -$2.03 in 2022 and averaged -$2.04.
  • In the last 5 years, Kura Oncology's EPS (Weighted Average and Diluted) decreased by 16.57% in 2021 and then grew by 2.88% in 2024.
  • Yearly analysis of 5 years shows Kura Oncology's EPS (Weighted Average and Diluted) stood at -$1.69 in 2020, then dropped by 16.57% to -$1.97 in 2021, then dropped by 3.05% to -$2.03 in 2022, then decreased by 2.46% to -$2.08 in 2023, then grew by 2.88% to -$2.02 in 2024.